Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
15.82
-0.83
(-4.96%)
As of 8:19:56 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 11 | 10 |
| Avg. Estimate | 188.69M | 188.15M | 752.94M | 808.39M |
| Low Estimate | 188.2M | 185.43M | 748.15M | 787.8M |
| High Estimate | 190.17M | 190.27M | 759.77M | 849.57M |
| Year Ago Sales | 190.94M | 193.13M | 769.33M | 752.94M |
| Sales Growth (year/est) | -1.18% | -2.58% | -2.13% | 7.36% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| UP2.F | -- | -- | -- | -- |
| S&P 500 | 14.39% | 7.67% | 10.93% | 14.14% |
Upgrades & Downgrades
| Maintains | Roth MKM: Buy to Buy | 2/13/2025 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 2/13/2025 |
| Maintains | UBS: Neutral to Neutral | 2/13/2025 |
| Maintains | Needham: Buy to Buy | 2/13/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 1/30/2025 |
| Reiterates | Needham: Buy to Buy | 1/17/2025 |